Polomar Health Services PMHS
OTC PMHS
$0.16 -0.01 (-5.88%)
At close: Oct 1, 2026 · 4:00 PM EDT

Polomar Health Services (PMHS) Return on Sales [ROS] (2022 - 2026)

Updated

Polomar Health Services (PMHS) reported Return on Sales [ROS] of 14.29% for Q2 2026, up 10312.88 percentage points from -10298.59% a year earlier and up 14.97 percentage points from the prior quarter.

Analysis

Polomar Health Services (PMHS) Return on Sales [ROS] (2022 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Polomar Health Services' Return on Sales [ROS] came in at -295.04%, up 4436.06 percentage points year-over-year; for FY2025, it was -1627.55%, up 581.58 percentage points from FY2024.

  • Return on Sales [ROS] has a three-year change of -1101.99 percentage points (FY2022 to FY2025).
  • By year, Return on Sales [ROS] came in at -2209.13% in FY2024 (-1155.61 pp), -1053.51% in FY2023 (-527.96 pp) and -525.55% in FY2022.
  • The Q2 2026 figure ranks as the highest quarterly Return on Sales [ROS] in data going back to Q3 2022.
  • Year over year, Return on Sales [ROS] has now increased in each of the last three quarters, with an average year-over-year change of -991.84 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Sales [ROS] in five years was Q2 2026 (a gain of 10312.88 percentage points); the low point was Q2 2025 (a drop of 8982.68 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -0.69% (Q1 2026), -1414.86% (Q4 2025) and -10202.95% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Polomar Health Services 4.52 Mn 4.09 Mn 935,916.00 14.29%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.29%
Mar 31, 2026 -0.69%
Dec 31, 2025 -1,414.86%
Sep 30, 2025 -10,202.95%
Jun 30, 2025 -10,298.59%
Mar 31, 2025 -9,145.93%
Dec 31, 2024 -3,301.93%
Sep 30, 2024 -2,631.47%
Jun 30, 2024 -1,315.92%
Mar 31, 2024 -1,179.04%
Dec 31, 2023 -546.84%
Sep 30, 2023 -627.66%
Dec 31, 2022 -506.59%
Sep 30, 2022 -298.67%
API Access

Polomar Health Services Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=PMHS&period=max&api_key=YOUR_API_KEY